semaglutide 25 mg weight loss Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) Arti Thangudu MD|Endocrinologist (Diabetes/Thyroid/Weight Loss)
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
















:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)



![Cannon 12lb Flash Weight [2295190] Brand_KVH](https://cdn.shopify.com/s/files/1/0715/2818/6141/products/28354XL.jpg?v=1676431221)


